LENZ Therapeutics, Inc. (LENZ) Misses Q2 EPS by 40c
Tweet
Share
E-mailGet Alerts LENZ Hot Sheet
Join SI Premium – FREE
LENZ Therapeutics, Inc. (NASDAQ: LENZ) reported Q2 EPS of ($0.40).
For earnings history and earnings-related data on LENZ Therapeutics, Inc. (LENZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Upgrades Healius Limited (HLS:AU) (PHCRF) to Sector Perform
- HSBC Downgrades PB Fintech Limited (POLICYBZ:IN) to Hold
- Barclays Starts Ligand Pharma (LGND) at Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
